How can I model large molecules like macrocycles?
What comprises large molecules? When we talk about “large molecules,” we often think of biologics like monoclonal antibodies, proteins, and…
3D molecular modelling plays a vital role in modern drug discovery, offering powerful applications to streamline research, reduce costs, and deepen molecular understanding. However, it also comes with challenges that can limit its effectiveness and accessibility. In this post, we explore key factors to consider when selecting 3D modelling software.
While 3D molecular modelling technology does bring long-term time and cost-savings, the price tag can be substantial, ranging anywhere from $50,000 to $1,000,000 per year, with additional costs for computational resources, support, training, and maintenance. Therefore, it’s essential that buyers thoroughly assess various factors before making a purchase to make sure they get the most return on their investment.
Ensure that the software’s features match the specific challenges you’re looking to address. For 3D molecular modeling, consider the following applications:
While each use case has its own unique strengths, they are highly complementary and can bring added value when used in combination.
Evaluate how well the software will integrate with your existing workflows and other tools you are using. Think, can it handle your current and future computational demands, especially for large-scale projects?
Consider the required customer support, user guides, and training that will be needed to ensure you get the most out of the software. For 3D modelling platforms, the amount of support required will depend on the users’ computational expertise and the accessibility of the software. Does the technology offer intuitive graphical user interfaces (GUIs), or is it predominantly accessed through the command line?
For instance, over the past decade, the BioPharmics platform has been primarily accessed from the command line by computational chemists, molecular modellers and technically adept experimental scientists. However, recently some of the functionality has been implemented in a PyMol GUI, making it very simple and easy to use, opening up these capabilities to non-expert users.
Unlike many 3D modelling platforms that are licensed on a per-token basis, we’ve opted for a straightforward approach with BioPharmics. Our all-inclusive licensing model supports unlimited users and CPU usage across the entire suite of methods:
This means anyone in your organization can use the platform as needed without worrying about usage limits or additional fees. Your annual subscription fee (ranging from $100,000 to $250,000 depending on organization size) includes everything you need to succeed, including comprehensive training and ongoing support from our application scientists.
Why have we chosen this way? We believe it has a number of benefits:
When selecting 3D molecular modelling software, carefully weighing capabilities against cost structure is crucial for maximising your investment. The right solution should provide robust tools while offering transparent pricing that aligns with your workflow and research goals.
BioPharmics represents one approach to addressing these considerations through its inclusive licensing model. If you’re interested in exploring how these capabilities could enhance your 3D drug design efforts, book a demo to discover if it aligns with your specific requirements.
Account Manager
Kylee holds a Masters in Pharmaceutical Sciences, and an MBA from Concordia University-Wisconsin.
What comprises large molecules? When we talk about “large molecules,” we often think of biologics like monoclonal antibodies, proteins, and…
In this paper, we describe an extended benchmark for non-cognate docking of macrocyclic ligands, and the superior performance of Surflex-Dock…
We introduce the ForceGen method for 3D structure generation and conformer elaboration of drug-like small molecules.